Princeton and Chennai, December 15, 2021:  Kedaara, a leading private equity firm, today announced the acquisition of a significant majority stake in Neurealm Limited (Neurealm). Neurealm is an AI-led digital transformation company that focuses on differentiated managed services and product engineering in Healthcare, Retail, BFSI and other verticals. Neurealm has grown its revenue at a stellar rate of 20%+ over the last five years (10x+ in the last 10 years) and has partnered with a strong line of global clients in the USA, India, and Middle East. Neurealm was awarded the “Star Performer” in Healthcare at PEAK Matrix Service Provider of the Year 2021 by Everest Group.

Kedaara’s investment will enable Neurealm to:

• Accelerate business growth by leveraging global relationships of Kedaara and Clayton, Dubilier & Rice (“CD&R”), a top global private equity firm and JV partner of Kedaara
• Deliver AI-led digital transformation services, enterprise managed services, and product engineering to a vast pool of customers globally, especially across healthcare enterprises
• Drive growth of ZIF.ai (Zero Incident Framework^TM), an AI-based TechOps platform
• Be among the Best Employers, and provide all of you an enriching and purposeful environment

Sunish Sharma, Co-CEO and Managing Partner of Kedaara, and Parin Mehta, Managing Director of Kedaara, said, “Cost efficiency improvements, the adoption of the value-based model, changing consumer expectations, the complexity of contracts and regulatory push are accelerating the adoption of digital technology.  We are excited to partner with the Neurealm team to support their continued effort in working with clients to aid that transition. Sumit and the senior leadership team have built a robust platform at Neurealm, with exceptional capabilities, focus on innovation, and partnerships with world-class clients, especially in the Healthcare sector.”

“Status-quo is not an option – businesses have constantly evolved to leverage advances in technology to increase agility, customer satisfaction, growth and profits. Today, this evolution includes the digital transformation of the business models and, subsequently, the IT operations of organizations. COVID-19 has only accelerated work in this direction,” said Pramod Bhasin, Operating Partner, Kedaara, and former President and CEO, Genpact. “With a strong DNA of innovation-led culture and customer-centricity, Neurealm is well-positioned to be one of the premier AI-led digital transformation focused service providers,” he added.

As per Gartner, the worldwide enterprise healthcare providers market is forecast to increase by 7.3% in 2021 to USD 124.2 billion, up from USD115.8 billion in 2020 and the worldwide healthcare spending on IT to achieve a five-year compound annual growth rate (CAGR) of 7.1% and to reach an estimated USD 162.8 billion by 2025.

Rajeev Srivastava, Executive Chairman and Managing Partner, Basil Technology Partners and Sameer Kanwar, Chief Executive Officer and General Partner, Basil Technology Partners said, “Over the past 12 years, we have been involved in scaling Neurealm into a 2,100+ person, innovation-led organization. Kedaara coming in as the majority shareholder will enable Neurealm to further build on its strengths and take advantage of the growing need for digital adoption across industries (especially in Healthcare) in the US and India, leveraging Kedaara and CD&R’s extensive network and relationships.”

Keith Pitts, Operating Advisor, Clayton, Dubilier & Rice, ex-Vice Chairman, Tenet Health, one of the leading healthcare systems in the US said, “Historically, the healthcare sector in the US has been slower to adopt IT as compared to players in the BFSI, retail sector, and consumer sector etc. But now, digital adoption has become an imperative. The abundance of untapped data and the increased focus on improving patient experience, and regulatory push are likely to drive IT adoption in healthcare, especially in the space of cloud migration, data analytics, and security services. Neurealm is well-positioned to capitalize on the spend on digital transformation initiatives by healthcare providers.”

Since 2010, Neurealm has engaged with BronxCare Health System, a leading healthcare provider in New York, to provide AI-led managed IT services and software support. Neurealm’ AI-based Tech-Ops product ZIF.ai resulted in improved IT infrastructure reliability of 99.9% at the hospital and a cost out of almost 30% for BronxCare Health System. In 2020, BronxCare entered into a contract for another 10 years, with Neurealm.

The Jewish Board, is New York City’s largest health and human services agency serving over 40,000 New Yorkers annually. Uday Madasu, CIO, Jewish Board said, “Jewish Board has been associated with Neurealm for the past 8 Years in providing end-to-end IT Support services. Through their AI led IT support services, they have been able to improve the reliability of our IT systems and have delivered about 35% cost savings YoY.”

Sumit Ganguli, CEO, Neurealm, said, “At Neurealm, all my colleagues and I are committed to building an AI-led digital transformation company with a focus on successful client engagements. We were most impressed with the leadership, competency, and aspirations at Kedaara and CD&R. We feel privileged to partner with them to pursue our vision. Kedaara’s investment in Neurealm is a testament to the culture of technological innovation, client centricity, and employee engagement that we have instilled in our company. Kedaara has significant experience in scaling businesses while retaining the entrepreneurial ethos in the portfolio companies. We believe that Kedaara and CD&R will be the ideal partners for Neurealm’ clients, employees, and for our stated values.”

Quillon Partners served as legal counsel, Ernst & Young served as the financial advisor, and Deloitte served as the tax advisor to Kedaara. Lexygen served as the legal counsel, KPMG served as tax advisor and Avendus Capital served as the exclusive financial advisor to Basil Technology Partners and Neurealm.

About Kedaara

Kedaara is an operationally oriented private equity firm pursuing control and minority investment opportunities in India. It currently advises / manages over ~US$ 3.9 billion through investments in several market leading businesses across a variety of sectors including consumer, financial services, pharma/healthcare, technology / business services and industrials. Kedaara’s operating partner model comprising former CEOs with proven track records of building market leading businesses that enables businesses to realize their full potential. Since its inception, Kedaara has remained singularly dedicated to its stated strategy of focusing on investments built through trust-based relationships with best-in-class entrepreneurs and management teams across secular fast growing end markets. Kedaara was co-founded by Manish Kejriwal, Sunish Sharma and Nishant Sharma and combines the strengths of a well-networked, highly experienced local investing and operating team, with the experience of their strategic partner, Clayton, Dubilier & Rice, a global private equity firm whose investment model blends financial skills with operating expertise.

For more information on Kedaara, please visit: https://kedaara.com

About Basil Technology Partners Pte. Ltd.

Basil Technology Partners Pte. Ltd. is a licensed fund manager in Singapore and is the advisor to Basil Technology Fund. Basil is a specialist technology investor that identifies and invests in niche technologies that are disrupting the IT services space. Basil has a hands-on approach to investing that leans heavily on identifying niche technology services companies, acquiring significant stakes, and being involved as an active operating partner in each of the portfolio companies to drive strategy, growth – both organic and inorganic – and exits. Basil has developed a reputation within the technology community in SE Asia, India and the U.S. for funding, growing and successfully exiting technology and tech-related businesses. Since 2008, the Basil team members have invested in and actively operated around 14 technology investments, with seven successful exits, mostly within 3 – 5 years of investment. In August, 2018 Basil completed a successful third-party fund-raising round from marquee international Limited Partners (LPs) to recapitalize and consolidate its position as an investor in several leading-edge niche technology companies.

For more information on Basil, please visit: www.basilpartners.com

About Neurealm

Neurealm, backed by Kedaara Capital, a leading Private Equity firm in India, is a global AI-led digital transformation company focused on creating business impact for its 200+ customers across the USA, Europe, the Middle East, and APAC. It offers digital product engineering, AI-led managed services, and digital transformation services to customers across healthcare, BFSI, and high-tech segments. With 4000+ technologists spread across 10+ global delivery centers and a robust talent-grooming engine, it is a trusted growth partner to its customers. Known for its innovative win-win business models, customer success focus, and deep tech engineering skills, the company invests heavily in emerging technologies such as 5G, edge computing, AI/ML, cloud, and IoT.

Contact

Anand Paramasamy
116 Village Blvd,
Princeton, NJ 08540
Phone: 609.951.2258
anand.paramasamy@Neurealmtech.com